| Old | New | Differences | |
|---|---|---|---|
| 1 | 1 | ||
| 2 | 2 | ||
| 3 | 3 | LCO No. 1389 1 of 1 | |
| 4 | 4 | ||
| 5 | 5 | General Assembly Proposed Bill No. 649 | |
| 6 | 6 | January Session, 2021 | |
| 7 | 7 | LCO No. 1389 | |
| 8 | 8 | ||
| 9 | 9 | ||
| 10 | 10 | Referred to Committee on GENERAL LAW | |
| 11 | 11 | ||
| 12 | 12 | ||
| 13 | 13 | Introduced by: | |
| 14 | 14 | SEN. LOONEY, 11th Dist. | |
| 15 | 15 | ||
| 16 | 16 | ||
| 17 | 17 | ||
| 18 | 18 | AN ACT CONCERNING THE AVAILABILITY OF GENERIC | |
| 19 | 19 | PHARMACEUTICALS. | |
| 20 | 20 | Be it enacted by the Senate and House of Representatives in General | |
| 21 | 21 | Assembly convened: | |
| 22 | 22 | ||
| 23 | 23 | That the general statutes be amended to prohibit "pay for delay" 1 | |
| 24 | 24 | contracts between name brand and generic pharmaceutical companies. 2 | |
| 25 | 25 | Statement of Purpose: | |
| 26 | 26 | To preserve patient access to affordable prescription drugs. |